Paper6089415
Nucleotide sequence of a region of the herpes simplex virus type 1 gB glycoprotein gene: mutations affecting rate of virus entry and cell fusion.
Bzik DJ and 3 others. Virology, 1984. Cited by 177 papers, by iCite.
Cite this record
ConductScience Library. Nucleotide sequence of a region of the herpes simplex virus type 1 gB glycoprotein gene: mutations affecting rate of virus entry and cell fusion. Papers, record 6089415. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6089415
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nucleotide sequence of a region of the herpes simplex virus type 1 gB glycoprotein gene: mutations affecting rate of virus entry and cell fusion.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genes | Major topic |
| Genes, Viral | Major topic |
| Mutation | Major topic |
| Simplexvirus | Major topic |
| Viral Envelope Proteins | Major topic |
| Viral Proteins | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| Cell Fusion | |
| DNA Restriction Enzymes | |
| Plasmids |
Source PubMed
Cited by109
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 177 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42693538 | Syncytium-forming HSV-1 in cancer gene therapy: From molecular mechanisms to clinical translation. | Virulence | 2026 | https://conductscience.org/library/papers/42693538 | PubMed |
| 41826436 | Human herpesvirus evasion of humoral immunity and implications for vaccine development. | Nat Rev Microbiol | 2026 | https://conductscience.org/library/papers/41826436 | PubMed |
| 41754506 | Host Cell Receptor and Herpes Simplex Virus 1 Glycoprotein B Are Determinants of Low Temperature Entry. | Viruses | 2026 | https://conductscience.org/library/papers/41754506 | PubMed |
| 41345806 | Retargeted oncolytic viruses engineered to remodel the tumor microenvironment for glioblastoma immunotherapy. | Nat Cancer | 2025 | https://conductscience.org/library/papers/41345806 | PubMed |
| 40981481 | Mutational dissection of HCMV gB and gH cytoplasmic tails highlights conserved and divergent features of fusion regulation. | mBio | 2025 | https://conductscience.org/library/papers/40981481 | PubMed |
| 40733610 | The Cytoplasmic Tail of Ovine Herpesvirus 2 Glycoprotein B Affects Cell Surface Expression and Is Required for Membrane Fusion. | Viruses | 2025 | https://conductscience.org/library/papers/40733610 | PubMed |
| 40573333 | Molecular Mechanisms of Cell-to-Cell Transmission in Human Herpesviruses. | Viruses | 2025 | https://conductscience.org/library/papers/40573333 | PubMed |
| 38400027 | Herpes Simplex Virus 1 Glycoprotein B from a Hyperfusogenic Virus Mediates Enhanced Cell-Cell Fusion. | Viruses | 2024 | https://conductscience.org/library/papers/38400027 | PubMed |
| 37996683 | Virus-Induced Cell Fusion and Syncytia Formation. | Results Probl Cell Differ | 2024 | https://conductscience.org/library/papers/37996683 | PubMed |
| 37808279 | Mechanism of herpesvirus UL24 protein regulating viral immune escape and virulence. | Front Microbiol | 2023 | https://conductscience.org/library/papers/37808279 | PubMed |
| 35767585 | A surface pocket in the cytoplasmic domain of the herpes simplex virus fusogen gB controls membrane fusion. | PLoS Pathog | 2022 | https://conductscience.org/library/papers/35767585 | PubMed |
| 34766141 | Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma. | MedComm (2020) | 2021 | https://conductscience.org/library/papers/34766141 | PubMed |
| 34553018 | Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus. | Mol Ther Oncolytics | 2021 | https://conductscience.org/library/papers/34553018 | PubMed |
| 34437654 | Herpes simplex virus 2 (HSV-2) evolves faster in cell culture than HSV-1 by generating greater genetic diversity. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/34437654 | PubMed |
| 34170814 | Combination of long- and short-read sequencing fully resolves complex repeats of herpes simplex virus 2 strain MS complete genome. | Microb Genom | 2021 | https://conductscience.org/library/papers/34170814 | PubMed |
| 33348900 | Virus-Mediated Cell-Cell Fusion. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33348900 | PubMed |
| 32296542 | In vitro evolution of herpes simplex virus 1 (HSV-1) reveals selection for syncytia and other minor variants in cell culture. | Virus Evol | 2020 | https://conductscience.org/library/papers/32296542 | PubMed |
| 31720372 | Intravenous Injections of a Rationally Selected Oncolytic Herpes Virus as a Potent Virotherapy for Hepatocellular Carcinoma. | Mol Ther Oncolytics | 2019 | https://conductscience.org/library/papers/31720372 | PubMed |
| 30560044 | First Impressions-the Potential of Altering Initial Host-Virus Interactions for Rational Design of Herpesvirus Vaccine Vectors. | Curr Clin Microbiol Rep | 2018 | https://conductscience.org/library/papers/30560044 | PubMed |
| 29728654 | Structural basis for membrane anchoring and fusion regulation of the herpes simplex virus fusogen gB. | Nat Struct Mol Biol | 2018 | https://conductscience.org/library/papers/29728654 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| UBE3B | 89910 | PubTator's text mining | https://conductscience.org/library/genes/89910 |
Source NCBI Gene
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | K02720 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6089415
GET https://conductscience.org/api/papers/v1/6089415/cited_by?page=2